US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ANI Pharmaceuticals

69.77

+0.22000.32%

Volume:30.84K

Turnover:2.13M

Market Cap:1.51B

PE:-66.90

High:69.89

Open:69.31

Low:68.57

Close:69.55

Loading ...

Overview Company News Filings

SRPT Provides Pipeline Updates on Rare Muscular Disorder Therapies

ANI Pharmaceuticals (ANIP): Buy, Sell, or Hold Post Q4 Earnings?

ANI Pharmaceuticals Price Target Maintained With a $86.00/Share by Guggenheim

Guggenheim Sticks to Its Buy Rating for ANI Pharmaceuticals (ANIP)

Vaxcyte Stock Plummets 56% in a Month: Here's the Reason

BMY Gets FDA Nod for Label Expansion of Opdivo plus Yervoy Combo

Will ANI (ANIP) Beat Estimates Again in Its Next Earnings Report?

Press Release: ANI Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 9, 2025, at 8:00 a.m. ET

VRTX Secures Nod for Expanded Use of CF Drug Kaftrio in Europe

FDA Grants Three Fast Track Tags to Allogene's Autoimmune Disease Drug

Zacks.com featured highlights ANI Pharmaceuticals, Expand Energy, Avista Corp and Contango ORE

Tariff Woes? Play Safe With 4 Low-Beta Stocks: ANIP, EXE, AVA & CTGO

SRPT Stock Down After EMA Places Clinical Hold on DMD Gene Therapy

BMRN's PKU Drug Palynziq Meets Goal in Late-Stage Pediatric Study

Is the Options Market Predicting a Spike in ANI Pharmaceuticals (ANIP) Stock?

LXRX Stock Moves Up 30% in a Week: What is Driving This Rally?

3 Russell 2000 Stocks in the Doghouse

Zacks.com featured highlights include HIS, ANI Pharmaceuticals, Pediatrix Medical, Fresenius Medical Care and LendingTree

CORT Shares Rise as Relacorilant Combo Meets Ovarian Cancer Study Goal

ANI Pharmaceuticals to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ANIP/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ANIP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANIP\",,,,,undefined,":{"symbol":"ANIP","market":"US","secType":"STK","nameCN":"ANI Pharmaceuticals","latestPrice":69.77,"timestamp":1744817055914,"preClose":69.55,"halted":0,"volume":30838,"delay":0,"floatShares":16768500,"shares":21585039,"eps":-1.042913,"marketStatus":"Trading","change":0.22,"latestTime":"04-16 11:24:47 EDT","open":69.31,"high":69.885,"low":68.57,"amount":2134826.54332,"amplitude":0.018907,"askPrice":69.78,"askSize":11,"bidPrice":69.53,"bidSize":20,"shortable":3,"etf":0,"ttmEps":-1.042913,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1744833600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1064980800000,"exchange":"NASDAQ","adjPreClose":69.55,"preHourTrading":{"tag":"盘前","latestPrice":68.61,"preClose":69.55,"latestTime":"07:28 EDT","volume":219,"amount":15028.07784,"timestamp":1744802882913},"postHourTrading":{"tag":"盘后","latestPrice":69.55,"preClose":69.55,"latestTime":"18:52 EDT","volume":8077,"amount":561631.63,"timestamp":1744757536913},"volumeRatio":0.253796,"impliedVol":0.669,"impliedVolPercentile":0.9641},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANIP\",,,,,undefined,":{"symbol":"ANIP","floatShares":16768500,"roa":"0.84%","roe":"-4.18%","lyrEps":-1.042913,"volumeRatio":0.253796,"shares":21585039,"dividePrice":0,"high":69.885,"amplitude":0.018907,"preClose":69.55,"low":68.57,"week52Low":52.5,"pbRate":"3.73","psRate":"2.45","week52High":70,"institutionHeld":0.9147,"latestPrice":69.77,"committee":0.290323,"eps":-1.042913,"divideRate":0,"volume":30838,"delay":0,"ttmEps":-1.042913,"open":69.31,"prevYearClose":55.28,"prevWeekClose":68.12,"prevMonthClose":66.95,"prevQuarterClose":66.95,"fiveDayClose":66.01,"twentyDayClose":64.87,"sixtyDayClose":58.35,"earningDate":1746720000000,"earningTime":"盘前"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ANIP\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2527217592","title":"SRPT Provides Pipeline Updates on Rare Muscular Disorder Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2527217592","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527217592?lang=en_us&edition=fundamental","pubTime":"2025-04-16 19:32","pubTimestamp":1744803120,"startTime":"0","endTime":"0","summary":"Sarepta Therapeutics SRPT announced updates from its clinical programs, which focus on targeting different subtypes of limb-girdle muscular dystrophy , a group of rare genetic disorders marked by progressive muscle weakness.Following positive FDA feedback, the company is advancing a fourth LGMD program to clinical development. Sarepta will soon start screening and dosing patients in the first-in-human clinical SRP-9005-101  study, to evaluate its investigational gene therapy SRP-9005 for LGMD type 2C/R5 .SRPT also announced completion of enrollment and dosing in the phase I proof-of-concept SRP-9004-102  study, which is evaluating SRP-9004 in patients with LGMD type 2D/R3 .The company also reiterated its plans to report data from the late-stage EMERGENE study, evaluating SRP-9003 in patients with LGMD type 2E/R4 , by first-half 2025. This study’s primary endpoint is the biomarker expression of the beta-sarcoglycan protein, whose absence is the sole cause of the disease. Following a pre","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/srpt-provides-pipeline-updates-rare-113200363.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","CTMX","IE00BJT1NW94.SGD","LU0566484027.USD","IE0002141913.USD","LU1559883803.SGD","RHHBY","IE0009355771.USD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","SRPT","03165","IE00BFTCPJ56.SGD","BK4585","BK4007","ANIP"],"gpt_icon":0},{"id":"2527948964","title":"ANI Pharmaceuticals (ANIP): Buy, Sell, or Hold Post Q4 Earnings?","url":"https://stock-news.laohu8.com/highlight/detail?id=2527948964","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527948964?lang=en_us&edition=fundamental","pubTime":"2025-04-15 17:10","pubTimestamp":1744708248,"startTime":"0","endTime":"0","summary":"Even during a down period for the markets, ANI Pharmaceuticals has gone against the grain, climbing to $68.06. Its shares have yielded a 16.1% return over the last six months, beating the S&P 500 by 23%. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.Is there a buying opportunity in ANI Pharmaceuticals, or does it present a risk to your portfolio?Dive into our full research report to see our analyst team’s opinion, it’s free.We’re glad investors have benefited from the price increase, but we don't have much confidence in ANI Pharmaceuticals. Here are three reasons why you should be careful with ANIP and a stock we'd rather own.With a diverse portfolio of 116 pharmaceutical products and a growing rare disease platform, ANI Pharmaceuticals  develops, manufactures, and markets branded and generic prescription pharmaceuticals, with a focus on rare disease treatments.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ani-pharmaceuticals-anip-buy-sell-091048537.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ANIP","POST"],"gpt_icon":0},{"id":"2526181695","title":"ANI Pharmaceuticals Price Target Maintained With a $86.00/Share by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2526181695","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526181695?lang=en_us&edition=fundamental","pubTime":"2025-04-11 22:21","pubTimestamp":1744381260,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ANIP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 11, 2025 10:21 ET (14:21 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANIP"],"gpt_icon":0},{"id":"2526500796","title":"Guggenheim Sticks to Its Buy Rating for ANI Pharmaceuticals (ANIP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2526500796","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526500796?lang=en_us&edition=fundamental","pubTime":"2025-04-11 19:35","pubTimestamp":1744371328,"startTime":"0","endTime":"0","summary":"In a report released today, Vamil Divan from Guggenheim reiterated a Buy rating on ANI Pharmaceuticals (ANIP – Research Report), with a price targe...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/guggenheim-sticks-to-its-buy-rating-for-ani-pharmaceuticals-anip?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/guggenheim-sticks-to-its-buy-rating-for-ani-pharmaceuticals-anip?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ANIP"],"gpt_icon":0},{"id":"2526543593","title":"Vaxcyte Stock Plummets 56% in a Month: Here's the Reason","url":"https://stock-news.laohu8.com/highlight/detail?id=2526543593","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526543593?lang=en_us&edition=fundamental","pubTime":"2025-04-11 01:07","pubTimestamp":1744304820,"startTime":"0","endTime":"0","summary":"Vaxcyte PCVX is a clinical-stage biotech focused on developing vaccines to prevent or treat bacterial infectious diseases.In the past month, PCVX's shares have nosedived 56%. This downside came after Vaxcyte reported mixed results from a phase II study on its investigational pneumococcal conjugate vaccine  in healthy infants.Adding to this headwind, the broader biotech/drug sector is feeling the pressure from the resignation of a senior FDA official instrumental in driving biotech innovation, which has raised alarms around the agency’s ability to maintain momentum on innovation and regulatory clarity.Vaxcyte’s shares have plummeted more than 62% year to date compared with the industry’s 8% decline, as seen in the chart below. During this timeframe, the stock has also underperformed the broader Medical sector and the S&P 500 Index. The company’s shares are also trading below its 50 and 200-day moving averages.Vaxcyte intends to report full post-dose 4 booster data for VAX-24 by the end ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vaxcyte-stock-plummets-56-month-170700030.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0566484027.USD","LU1894683348.USD","SG9999001176.SGD","BK4139","IE000M9KFDE8.USD","LU0985481810.HKD","LU0306806265.USD","LU1057294990.SGD","LU1066051498.USD","LU0225284248.USD","BK4599","LU0321505868.SGD","BK4568","LU1066053197.SGD","SG9999013999.USD","PFE","LU0170899867.USD","BK4581","LU0122379950.USD","PCVX","LU1559883803.SGD","LU0234572021.USD","BK4550","ETNB","BK4534","BK4592","IE0009354923.USD","SG9999002232.USD","LU0868494617.USD","LU1883839398.USD","BK4533","LU0289739699.SGD","IE0002270589.USD","IE00BLSP4239.USD","LU0058720904.USD","BK4585","LU0306807586.USD","SGXZ57979304.SGD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","IE00BLSP4452.SGD","SG9999011175.SGD","ANIP","LU1023059063.AUD","LU0053671581.USD","LU0225771236.USD","BK4007","BK4588","LU0456855351.SGD"],"gpt_icon":1},{"id":"2526131059","title":"BMY Gets FDA Nod for Label Expansion of Opdivo plus Yervoy Combo","url":"https://stock-news.laohu8.com/highlight/detail?id=2526131059","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526131059?lang=en_us&edition=fundamental","pubTime":"2025-04-10 01:44","pubTimestamp":1744220640,"startTime":"0","endTime":"0","summary":"Bristol Myers Squibb BMY announced that it has obtained FDA approval for the label expansion of Opdivo  plus Yervoy .The regulatory body approved Opdivo plus Yervoy as a first-line treatment of adult and pediatric patients  with unresectable or metastatic microsatellite instability-high  or mismatch repair deficient  colorectal cancer .Please note that Opdivo , as a single agent or in combination with Yervoy, was previously granted accelerated approval in MSI-H/dMMR CRC in adult and pediatric patients  who have progressed following treatment with fluoropyrimidine, oxaliplatin and irinotecan.The latest FDA approval converts this second-line indication to full approval for Opdivo monotherapy and expands the indication for Opdivo plus Yervoy into the first-line setting.Shares of BMY have risen 7.9% in the past year against the industry’s decline of 20%.This randomized, multicenter, open-label study is evaluating Opdivo plus Yervoy compared to Opdivo alone or chemotherapy in patients with ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bmy-gets-fda-nod-label-174400443.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0306806265.USD","LU1670710661.SGD","LU2242652126.USD","BK4534","LU0985481810.HKD","LU1718418525.SGD","LU0456855351.SGD","LU1989771016.USD","LU1093756168.USD","LU1323610961.USD","BK4585","LU1868836757.USD","LU1585245621.USD","FOLD","IE00BFTCPJ56.SGD","LU1559883803.SGD","LU2360032135.SGD","CRC","LU2065170008.USD","LU0266512127.USD","LU2065169927.USD","LU1670711040.USD","IE00BSNM7G36.USD","LU2125154778.USD","BK4532","BMY","BK4139","IE00BFXG1179.USD","ANIP","IE00BJJMRZ35.SGD","LU0225771236.USD","LU0321505868.SGD","LU1430594728.SGD","LU1670711123.USD","LU2065171311.SGD","BK4559","LU2125154935.USD","LU1291159041.SGD","IE0002141913.USD","LU0114720955.EUR","LU0061475181.USD","LU1032466523.USD","LU0868494617.USD","LU1261432733.SGD","BK4588","LU0321505439.SGD","LU2065171402.SGD","LU0306807586.USD","LU0096364046.USD"],"gpt_icon":0},{"id":"2526315890","title":"Will ANI (ANIP) Beat Estimates Again in Its Next Earnings Report?","url":"https://stock-news.laohu8.com/highlight/detail?id=2526315890","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526315890?lang=en_us&edition=fundamental","pubTime":"2025-04-10 00:10","pubTimestamp":1744215012,"startTime":"0","endTime":"0","summary":"Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report?ANI Pharmaceuticals , which belongs to the Zacks Medical - Biomedical and Genetics industry, could be a great candidate to consider.When looking at the last two reports, this drugmaker has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 18.07%, on average, in the last two quarters.For the most recent quarter, ANI was expected to post earnings of $1.44 per share, but it reported $1.63 per share instead, representing a surprise of 13.19%. For the previous quarter, the consensus estimate was $1.09 per share, while it actually produced $1.34 per share, a surprise of 22.94%.With this earnings history in mind, recent estimates have been moving higher for ANI. In fact, the Zacks Earnings ESP  for the company is positive, which is a great sign of an earnings beat, especially when you combine t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ani-anip-beat-estimates-again-161012933.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ANIP"],"gpt_icon":0},{"id":"2526512013","title":"Press Release: ANI Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 9, 2025, at 8:00 a.m. ET","url":"https://stock-news.laohu8.com/highlight/detail?id=2526512013","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526512013?lang=en_us&edition=fundamental","pubTime":"2025-04-09 18:50","pubTimestamp":1744195800,"startTime":"0","endTime":"0","summary":"PRINCETON, N.J., April 09, 2025  -- ANI Pharmaceuticals, Inc.   today announced that the Company will release its first quarter 2025 financial results on Friday, May 9, 2025, prior to the market open.Nikhil Lalwani, President and Chief Executive Officer, Stephen P. Carey, Senior Vice President, Finance, and Chief Financial Officer, and Chris Mutz, Head of Rare Disease, will host a conference call to discuss the results as follows:. A replay of the conference call will be available within two hours of the call's completion and will remain accessible for two weeks by dialing 800-753-8591 and entering access code 4921902.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4144","BK4581","BK4588","ET","LU1559883803.SGD","BK4590","BK4561","LU0566484027.USD","BK4007","ANIP","BK4585"],"gpt_icon":0},{"id":"2525437894","title":"VRTX Secures Nod for Expanded Use of CF Drug Kaftrio in Europe","url":"https://stock-news.laohu8.com/highlight/detail?id=2525437894","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525437894?lang=en_us&edition=fundamental","pubTime":"2025-04-08 18:55","pubTimestamp":1744109700,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals VRTX announced that the European Commission  has expanded the label of its blockbuster cystic fibrosis  drug, Kaftrio, to treat all patients aged two years and older who have at least one non-class I mutation in the CFTR gene.This approval was expected as the EMA’s Committee for Medicinal Products for Human Use  issued a positive opinion recommending Kaftrio’s approval in February for the above indication. With this expanded label, nearly 4,000 more CF patients living in the region are now eligible for treatment with the drug.Kaftrio is already approved for use in CF patients aged two years and older who have at least one F508del mutation in the CFTR gene.The drug is marketed by Vertex for similar indications in the United States under the trade name Trikafta.Year to date, shares of Vertex have gained 18% against the industry’s 7% decline.Estimates for 89bio’s loss per share have narrowed from $2.51 to $1.98 for 2025 in the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vrtx-secures-nod-expanded-cf-105500149.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4551","LU0417517546.SGD","BK4007","BK4093","SG9999013999.USD","LU1585245621.USD","VRTX","ETNB","SGXZ57979304.SGD","VERX","LU2456880835.USD","LU2236285917.USD","LU1559883803.SGD","LU1093756168.USD","LU0757428866.USD","LU0823416689.USD","IE0002141913.USD","EC","BK4533","SG9999001176.USD","BK4567","IE00B19Z3B42.SGD","LU0289739699.SGD","IE00B894F039.SGD","BK4139","LU0320765992.SGD","IE0002270589.USD","BK4023","BK4588","LU2324357040.USD","BK4568","LU2462157665.USD","SG9999001176.SGD","IE00BZ9MQY76.HKD","LU2362541273.HKD","LU2237438978.USD","ANIP","CF","IE00BFTCPJ56.SGD","LU0109394709.USD","LU2362540622.SGD","IE00BJT1NW94.SGD","LU2417539215.USD","LU1430594728.SGD","IE00B19Z9P08.USD","LU1035775433.USD","IE00BJJMRZ35.SGD","BK4201"],"gpt_icon":1},{"id":"2525318890","title":"FDA Grants Three Fast Track Tags to Allogene's Autoimmune Disease Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2525318890","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525318890?lang=en_us&edition=fundamental","pubTime":"2025-04-08 18:46","pubTimestamp":1744109160,"startTime":"0","endTime":"0","summary":"Allogene Therapeutics ALLO announced that the FDA has granted three fast track designations to its investigational CRISPR-based allogeneic CAR-T therapy, ALLO-329.These designations apply to three autoimmune diseases — systemic lupus erythematosus , idiopathic inflammatory myopathy  and diffuse systemic sclerosis .How Does the Fast Track Tag Benefit ALLO’s Drug Development?Fast track designation is designed to facilitate the development and expedite the review of drugs that treat serious conditions, meet an unmet medical need, or offer a potential advantage over existing treatments. Per the FDA, the purpose of granting this designation is to ‘get important new drugs to the patient earlier.’。In the past 60 days, estimates for CytomX Therapeutics’ 2025 EPS have improved from a loss of 31 cents to a profit of 25 cents. During the same timeframe, estimates for loss per share for 2026 have","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fda-grants-three-fast-track-104600523.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IIM","BK4077","ANIP","IE00B5TLWC47.USD","IE00BYQQ9H92.USD","BK4139","BK4567","FAST","ETNB","IE00BFXG0V08.USD","ALLO","BK4585","BK4104","BK4007","BK4588","CTMX","BK4505","SLE"],"gpt_icon":0},{"id":"2525864720","title":"Zacks.com featured highlights ANI Pharmaceuticals, Expand Energy, Avista Corp and Contango ORE","url":"https://stock-news.laohu8.com/highlight/detail?id=2525864720","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525864720?lang=en_us&edition=fundamental","pubTime":"2025-04-08 16:53","pubTimestamp":1744102380,"startTime":"0","endTime":"0","summary":"Chicago, IL – April 8, 2025 – Stocks in this week’s article are ANI Pharmaceuticals, Inc. ANIP, Expand Energy Corporation EXE, Avista Corp AVA and Contango ORE, Inc. CTGO.Play It Safe with 4 Low-Beta Stocks: ANIP, EXE, AVA, CTGO. President Donald Trump’s recently imposed tariff has rattled the equity market. The action will weigh on the already slowing domestic economy as the tariff will increase prices of both domestic and imported goods, thereby fueling uncertainty.Hence, stocks like ANI Pharmaceuticals, Inc., Expand Energy Corporation, Avista Corp and Contango ORE, Inc. are worth betting on.In the United States, Avista is among the leading utilities responsible for very low carbon emissions. To support its growing and large customer base, AVA has set up a solid capital investment program. From the estimated $525 million capital investment in 2025, AVA is planning to grow its investment to $650 million in 2029, securing a rate base growth of 5% to 6%. Notably, over the past 30 days, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zacks-com-featured-highlights-ani-085300951.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["EXEEZ","ANIP","LU1804176565.USD","AVA","EXEEL","LU2265009873.SGD","BK4168","BK4007","BK4208","BK4213","EXEEW","CTGO","EXE","LU1878469433.USD"],"gpt_icon":0},{"id":"2525041327","title":"Tariff Woes? Play Safe With 4 Low-Beta Stocks: ANIP, EXE, AVA & CTGO","url":"https://stock-news.laohu8.com/highlight/detail?id=2525041327","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525041327?lang=en_us&edition=fundamental","pubTime":"2025-04-07 20:23","pubTimestamp":1744028580,"startTime":"0","endTime":"0","summary":"President Donald Trump’s recently imposed tariff has rattled the equity market. The action will weigh on the already slowing domestic economy as the tariff will increase prices of both domestic and imported goods, thereby fueling uncertainty.In this context, creating a curated portfolio of low-beta stocks is a prudent strategy. This provides a safeguard against the uncertain market, equipping investors to navigate volatility with greater resilience and foresight.Beta measures the volatility or risk of a particular asset compared to the market. In other words, beta measures the extent of a security’s price movement relative to the market. In this article, we are considering the S&P 500 as the market.If a stock has a beta of 1, then the price of the stock will move with the market. So, the stock is more volatile than the market if its beta is more than 1. In the same way, the stock is not as volatile as the market if its beta is less than 1.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tariff-woes-play-safe-4-122300709.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["EXE","LU1804176565.USD","BK4007","BK4168","BK4213","LU1878469433.USD","CTGO","ANIP","BK4208","LU2265009873.SGD","AVA"],"gpt_icon":0},{"id":"2524420475","title":"SRPT Stock Down After EMA Places Clinical Hold on DMD Gene Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2524420475","media":"Zacks","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524420475?lang=en_us&edition=fundamental","pubTime":"2025-04-04 19:29","pubTimestamp":1743766140,"startTime":"0","endTime":"0","summary":"Shares of Sarepta Therapeutics SRPT dropped more than 6% yesterday after the EMA placed a clinical hold on all studies evaluating Elevidys, its one-shot gene therapy for Duchenne muscular dystrophy . The therapy has been developed in collaboration with pharma giant Roche RHHBY.This hold has been placed in response to a patient’s death post-treatment with Elevidys, which was reported last month. Though the death was due to acute liver failure , Sarepta believes that the patient’s recent CMV infection might have contributed to the outcome. Investigation is still ongoing.In a letter to the World Duchenne Organization, Roche mentioned that the companies are pausing enrollment and dosing of study participants in three studies evaluating the therapy at the EU study sites. This hold will remain ‘until the analysis into the cause of death is complete.’。SRPT and RHHBY entered into a licensing agreement in 2019 to develop Elevidys. Per the agreement, Sarepta retains the rights to market the gene","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/srpt-stock-down-ema-places-112900759.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["03165","RHHBY","ANIP","IE00B2B36J28.USD","IE0002141913.USD","IE00BJJMRZ35.SGD","SRPT","BK4585","IE00BJT1NW94.SGD","CTMX","IE0009355771.USD","BK4007","IE00BFTCPJ56.SGD","BK4139"],"gpt_icon":0},{"id":"2524260088","title":"BMRN's PKU Drug Palynziq Meets Goal in Late-Stage Pediatric Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2524260088","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524260088?lang=en_us&edition=fundamental","pubTime":"2025-04-03 22:14","pubTimestamp":1743689640,"startTime":"0","endTime":"0","summary":"BioMarin BMRN has announced positive results from the phase III PEGASUS study evaluating Palynziq  in adolescents aged 12-17 years with phenylketonuria .The study achieved its primary endpoint – patients treated with Palynziq achieved a statistically significant lowering in blood phenylalanine  levels compared to diet alone. The safety results were also consistent with the known profile of the drug.Palynziq is already approved in the United States to reduce blood Phe concentration in adults aged 18 years and older with PKU. The drug is currently the only enzyme therapy to treat the disease in this age group.PKU is a rare genetic disorder that prevents the body from breaking down Phe, an amino acid found in protein-rich foods, leading to toxic levels that can cause severe neurological damage. While newborn screening enables early diagnosis, lifelong dietary management is challenging, creating demand for innovative treatments like those developed by BioMarin.In the past 60 days, estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bmrns-pku-drug-palynziq-meets-141400981.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE0002270589.USD","BK4585","BK4139","BK4566","IE00B19Z3B42.SGD","BMRN","BK4007","ANIP","IE00B19Z3581.USD","SSI","IE00B7SZLL34.SGD","CTMX","ETNB"],"gpt_icon":0},{"id":"2524826457","title":"Is the Options Market Predicting a Spike in ANI Pharmaceuticals (ANIP) Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2524826457","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524826457?lang=en_us&edition=fundamental","pubTime":"2025-04-03 20:42","pubTimestamp":1743684120,"startTime":"0","endTime":"0","summary":"Investors in ANI Pharmaceuticals, Inc. ANIP need to pay close attention to the stock based on moves in the options market lately. That is because the Apr 17, 2025 $75.00 Put had some of the highest implied volatility of all equity options today.Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.Clearly, options traders are pricing in a big move for ANI Pharmaceuticals shares, but what is the fundamental picture for the company?ANI Pharmaceuticals, Inc.  : Free Stock Analysis Report. This article originally published on Zacks Investment Research .","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/options-market-predicting-spike-ani-124200284.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","ANIP"],"gpt_icon":0},{"id":"2524460415","title":"LXRX Stock Moves Up 30% in a Week: What is Driving This Rally?","url":"https://stock-news.laohu8.com/highlight/detail?id=2524460415","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524460415?lang=en_us&edition=fundamental","pubTime":"2025-04-02 22:18","pubTimestamp":1743603480,"startTime":"0","endTime":"0","summary":"Shares of Lexicon Pharmaceuticals LXRX have jumped 30% after signing a licensing deal for its pre-clinical obesity drug LX9851 with pharma giant Novo Nordisk NVO last week.Per the deal terms, Lexicon will complete certain preclinical activities before Novo Nordisk takes over the development, manufacturing and commercialization of LX9851. NVO will also be responsible for LX9851’s investigational new drug  filing.In return, LXRX is eligible to receive $75 million as an upfront payment from NVO. Including milestone payments, the deal is worth up to $1 billion. Lexicon will also earn tiered royalties on potential net sales of the drug.Post the above setback, LXRX decided to discontinue developing the drug for the T1D indication and announced plans to reduce its workforce by 60%.A couple of better-ranked stocks from the sector are ANI Pharmaceuticals ANIP and 89bio ETNB. ANIP sports a Zacks Rank #1  at present and ETNB carries a Zacks Rank #2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lxrx-stock-moves-30-week-141800883.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1093756325.SGD","LU0154236417.USD","LU1093756168.USD","NVO","LXRX","BK4585","ETNB","ANIP","BK4139","IE00BZ1G4Q59.USD","BK4599","BK4532","BK4007","BK4588","IE00BKVL7J92.USD"],"gpt_icon":1},{"id":"2524749067","title":"3 Russell 2000 Stocks in the Doghouse","url":"https://stock-news.laohu8.com/highlight/detail?id=2524749067","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524749067?lang=en_us&edition=fundamental","pubTime":"2025-04-02 21:04","pubTimestamp":1743599084,"startTime":"0","endTime":"0","summary":"Small-cap stocks in the Russell 2000 can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.Picking the right small caps isn’t easy, and that’s exactly why StockStory exists - to help you focus on the best opportunities. Keeping that in mind, here are three Russell 2000 stocks to avoid and better alternatives to consider.Focus on expanding its platform came at the expense of monetization as its average revenue per buyer fell by 1.8% annually. Earnings per share lagged its peers over the last three years as they only grew by 1.5% annually. Earnings per share were flat while its revenue grew over the last five years, partly because it issued new shares. ANI Pharmaceuticals is trading at $68 per share, or 12.9x forward price-to-earnings. Read our free research report to see why you should think twice about including ANIP in your","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-russell-2000-stocks-doghouse-130444888.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["USJW.SI","TSYW.SI","BK4018","NVIW.SI","UDMY","CENTA","USAW.SI","SQQQ","QID","TQQQ","QLD","MNQmain","BK4204","NQmain","ANIP","PSQ","BK4007","CENT",".IXIC"],"gpt_icon":1},{"id":"2524449758","title":"Zacks.com featured highlights include HIS, ANI Pharmaceuticals, Pediatrix Medical, Fresenius Medical Care and LendingTree","url":"https://stock-news.laohu8.com/highlight/detail?id=2524449758","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524449758?lang=en_us&edition=fundamental","pubTime":"2025-04-02 20:35","pubTimestamp":1743597300,"startTime":"0","endTime":"0","summary":"Chicago, IL – April 2, 2025 – Stocks in this week’s article are IHS Holding Ltd. IHS, ANI Pharmaceuticals, Inc. ANIP, Pediatrix Medical Group MD, Fresenius Medical Care AG FMS and LendingTree TREE.5 Relative Price Strength Stocks to Navigate Today's Market. The U.S. stock market took a wild ride in the first quarter of 2025, as the S&P 500 notched its biggest quarterly loss in nearly three years. Market sentiment suffered a blow as President Trump's aggressive tariff policies rekindled fears of a global trade war, a powerful dampener on investor sentiment. The index fell 4.6%, ending a five-quarter winning streak and raising fears about economic growth. Concerns about inflation and wild swings in consumer sentiment added to market volatility, prompting analysts to raise recession odds and adjust their projections accordingly.At this stage, investors would be wise to consider stocks like IHS Holding Ltd., ANI Pharmaceuticals, Inc., Pediatrix Medical Group, Fresenius Medical Care AG and ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zacks-com-featured-highlights-ani-123500789.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TREE","ANIP","MD","BK4196","BK4166","FMS","BK4115","BK4007","IHS"],"gpt_icon":0},{"id":"2524128774","title":"CORT Shares Rise as Relacorilant Combo Meets Ovarian Cancer Study Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2524128774","media":"Zacks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524128774?lang=en_us&edition=fundamental","pubTime":"2025-04-01 22:50","pubTimestamp":1743519000,"startTime":"0","endTime":"0","summary":"Shares of Corcept Therapeutics Incorporated CORT were up a staggering 109.1% on March 31 after the company announced data from the phase III ROSELLA study, which evaluated its pipeline candidate, relacorilant, in combination with nab-paclitaxel for treating patients with platinum-resistant ovarian cancer.The ROSELLA study met its primary endpoint of improved progression-free survival, as assessed by blinded independent central review .Per management, data from the ROSELLA study suggested that the combo of relacorilant plus nab-paclitaxel has the potential to become a new standard of care for patients with platinum-resistant ovarian cancer.Year to date, shares of Corcept have skyrocketed 126.7% against the industry’s decline of 1.9%.The phase III ROSELLA study evaluated relacorilant in combination with nab-paclitaxel for treating patients with recurrent, platinum-resistant ovarian cancer.Data from the same showed that treatment with relacorilant plus nab-paclitaxel reduced the risk of d","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cort-shares-rise-relacorilant-combo-145000011.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","BK4139","ANIP","LU2065170008.USD","LU0566484027.USD","CTMX","LU2065171402.SGD","LU2065169927.USD","LU2065171311.SGD","FOLD","BK4097","CORT","OS","BK4532","LU1559883803.SGD"],"gpt_icon":0},{"id":"2524977388","title":"ANI Pharmaceuticals to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2524977388","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524977388?lang=en_us&edition=fundamental","pubTime":"2025-04-01 04:30","pubTimestamp":1743453000,"startTime":"0","endTime":"0","summary":"PRINCETON, N.J., March  31, 2025  (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, will","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/31/3052812/0/en/ANI-Pharmaceuticals-to-Present-at-2025-RBC-Capital-Markets-Ophthalmology-Virtual-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4207","BK4007","ANIP"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":1,"totalSize":179,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ANIP\",params:#limit:5,,,undefined,":[{"date":"2025-05-09","symbol":"ANIP","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":1.05,"defaultRemindTime":1746777600000,"name":null,"time":"Pre-Market","dateTimestamp":1746763200000,"actualEps":null},{"market":"US","date":"2025-02-28","symbol":"ANIP","fiscalQuarterEnding":"2024/12","expectedEps":1.14,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740718800000,"reportTimeType":"pre","actualEps":1.35},{"market":"US","date":"2025-01-13","symbol":"ANIP","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1736744400000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-11-08","symbol":"ANIP","fiscalQuarterEnding":"2024/09","expectedEps":0.76,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731042000000,"reportTimeType":"pre","actualEps":1.04},{"market":"US","date":"2024-08-06","symbol":"ANIP","fiscalQuarterEnding":"2024/06","expectedEps":0.64,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1722916800000,"reportTimeType":"pre","actualEps":0.72}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ANIP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ANIP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.375,"buy":0.5,"hold":0.125,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":8,"updateTime":1742011200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ANIP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ANIP","date":"2025-04-15","current":-75.345073,"percent":0.160554,"low":-311.184856,"twenty":-37.523284,"median":-16.067819,"eighty":32.74469,"high":92.86867,"avg":-35.233365,"sd":87.727994,"marketCap":1395541433},"quantilePoints":[{"date":"2020-04-17","current":84.253938,"twenty":21.569236,"median":49.501086,"eighty":175.341115,"marketCap":513443500},{"date":"2020-04-24","current":84.512513,"twenty":21.639216,"median":49.740542,"eighty":175.341115,"marketCap":515019254},{"date":"2020-05-01","current":78.483131,"twenty":21.68665,"median":49.897003,"eighty":175.341115,"marketCap":478276200},{"date":"2020-05-08","current":-306.724064,"twenty":21.68665,"median":49.897003,"eighty":174.662929,"marketCap":418985071},{"date":"2020-05-15","current":-276.747541,"twenty":21.639216,"median":49.740542,"eighty":171.157853,"marketCap":378037141},{"date":"2020-05-22","current":-281.654412,"twenty":21.569236,"median":49.501086,"eighty":129.970868,"marketCap":384739927},{"date":"2020-05-29","current":-277.104405,"twenty":21.540251,"median":49.4105,"eighty":114.118791,"marketCap":378524617},{"date":"2020-06-05","current":-287.007363,"twenty":21.490641,"median":49.320114,"eighty":112.769329,"marketCap":392052058},{"date":"2020-06-12","current":-279.334801,"twenty":21.43174,"median":49.19183,"eighty":110.88517,"marketCap":381571338},{"date":"2020-06-19","current":-267.023015,"twenty":21.397336,"median":49.143393,"eighty":110.230911,"marketCap":364753438},{"date":"2020-06-26","current":-271.84067,"twenty":21.260922,"median":48.961869,"eighty":109.609404,"marketCap":371334355},{"date":"2020-07-02","current":-275.587735,"twenty":21.213916,"median":48.819209,"eighty":108.674596,"marketCap":376452846},{"date":"2020-07-10","current":-242.656217,"twenty":21.146728,"median":48.595145,"eighty":107.483212,"marketCap":331468393},{"date":"2020-07-17","current":-267.608014,"twenty":21.004704,"median":48.464447,"eighty":106.487144,"marketCap":365552547},{"date":"2020-07-24","current":-236.240042,"twenty":20.955588,"median":48.183479,"eighty":105.494518,"marketCap":322703897},{"date":"2020-07-31","current":-263.865245,"twenty":20.91187,"median":47.740116,"eighty":104.82867,"marketCap":360439924},{"date":"2020-08-07","current":-17.948035,"twenty":20.772397,"median":47.399928,"eighty":102.855769,"marketCap":364111791},{"date":"2020-08-14","current":-19.147723,"twenty":20.710873,"median":47.109625,"eighty":102.014304,"marketCap":388449853},{"date":"2020-08-21","current":-18.462187,"twenty":20.602327,"median":46.853471,"eighty":100.138989,"marketCap":374542389},{"date":"2020-08-28","current":-18.474007,"twenty":20.558652,"median":46.566876,"eighty":99.313001,"marketCap":374782173},{"date":"2020-09-04","current":-17.227041,"twenty":20.458555,"median":46.389314,"eighty":97.780868,"marketCap":349484975},{"date":"2020-09-11","current":-16.322843,"twenty":20.389015,"median":46.259964,"eighty":95.080791,"marketCap":331141510},{"date":"2020-09-18","current":-17.942125,"twenty":20.307358,"median":45.914271,"eighty":94.158771,"marketCap":363991899},{"date":"2020-09-25","current":-16.10418,"twenty":20.231122,"median":45.803098,"eighty":93.899855,"marketCap":326705509},{"date":"2020-10-02","current":-16.896092,"twenty":20.188569,"median":45.677543,"eighty":93.899855,"marketCap":342771027},{"date":"2020-10-09","current":-18.190337,"twenty":20.1016,"median":45.515812,"eighty":93.831974,"marketCap":369027360},{"date":"2020-10-16","current":-17.605267,"twenty":20.025882,"median":45.358477,"eighty":93.831974,"marketCap":357158059},{"date":"2020-10-23","current":-17.108845,"twenty":19.935944,"median":45.290838,"eighty":93.831974,"marketCap":347087137},{"date":"2020-10-30","current":-15.064057,"twenty":19.853111,"median":45.178762,"eighty":93.831974,"marketCap":305604529},{"date":"2020-11-06","current":-11.966257,"twenty":19.635625,"median":45.101076,"eighty":93.831974,"marketCap":284174674},{"date":"2020-11-13","current":-14.042294,"twenty":19.43091,"median":45.101076,"eighty":93.831974,"marketCap":333476401},{"date":"2020-11-20","current":-14.15342,"twenty":19.270511,"median":45.101076,"eighty":93.831974,"marketCap":336115423},{"date":"2020-11-27","current":-14.890893,"twenty":19.083542,"median":45.101076,"eighty":93.831974,"marketCap":353628931},{"date":"2020-12-04","current":-14.815125,"twenty":18.677139,"median":45.033423,"eighty":93.831974,"marketCap":351829598},{"date":"2020-12-11","current":-15.118197,"twenty":18.135705,"median":44.963168,"eighty":93.831974,"marketCap":359026931},{"date":"2020-12-18","current":-15.744543,"twenty":17.809673,"median":44.893709,"eighty":93.831974,"marketCap":373901418},{"date":"2020-12-24","current":-14.143318,"twenty":17.67856,"median":44.788392,"eighty":93.831974,"marketCap":335875512},{"date":"2020-12-31","current":-14.668641,"twenty":17.562123,"median":44.750872,"eighty":93.831974,"marketCap":348350888},{"date":"2021-01-08","current":-15.81526,"twenty":17.494531,"median":44.671419,"eighty":93.831974,"marketCap":375580795},{"date":"2021-01-15","current":-16.229457,"twenty":17.372674,"median":44.671419,"eighty":93.831974,"marketCap":385417150},{"date":"2021-01-22","current":-16.209252,"twenty":17.122322,"median":44.671419,"eighty":93.831974,"marketCap":384937327},{"date":"2021-01-29","current":-14.416082,"twenty":16.943136,"median":44.671419,"eighty":93.831974,"marketCap":342353111},{"date":"2021-02-05","current":-15.512189,"twenty":16.763257,"median":44.671419,"eighty":93.831974,"marketCap":368383463},{"date":"2021-02-12","current":-15.906181,"twenty":16.268593,"median":44.671419,"eighty":93.831974,"marketCap":377739995},{"date":"2021-02-19","current":-15.274783,"twenty":15.830659,"median":44.671419,"eighty":93.831974,"marketCap":362745552},{"date":"2021-02-26","current":-14.698948,"twenty":-12.119813,"median":44.671419,"eighty":93.831974,"marketCap":349070621},{"date":"2021-03-05","current":-14.900996,"twenty":-13.866513,"median":44.684665,"eighty":93.840828,"marketCap":353868843},{"date":"2021-03-12","current":-17.719586,"twenty":-14.185748,"median":44.684665,"eighty":93.840828,"marketCap":399541231},{"date":"2021-03-19","current":-18.809938,"twenty":-14.28172,"median":44.684665,"eighty":93.840828,"marketCap":424126483},{"date":"2021-03-26","current":-17.905878,"twenty":-14.478717,"median":44.671419,"eighty":93.831974,"marketCap":403741726},{"date":"2021-04-01","current":-18.645563,"twenty":-14.700969,"median":44.671419,"eighty":93.831974,"marketCap":420420163},{"date":"2021-04-09","current":-17.456587,"twenty":-14.79391,"median":44.684665,"eighty":93.840828,"marketCap":393611120},{"date":"2021-04-16","current":-18.727751,"twenty":-14.933323,"median":44.684665,"eighty":93.840828,"marketCap":422273323},{"date":"2021-04-23","current":-18.490979,"twenty":-15.018183,"median":44.619273,"eighty":93.840828,"marketCap":416934604},{"date":"2021-04-30","current":-18.67617,"twenty":-15.151534,"median":44.517552,"eighty":93.840828,"marketCap":421110277},{"date":"2021-05-07","current":-30.006302,"twenty":-15.294988,"median":44.482394,"eighty":93.840828,"marketCap":463627379},{"date":"2021-05-14","current":-27.254429,"twenty":-15.522291,"median":44.482394,"eighty":93.840828,"marketCap":421108184},{"date":"2021-05-21","current":-27.503186,"twenty":-15.637458,"median":44.482394,"eighty":93.840828,"marketCap":424951727},{"date":"2021-05-28","current":-26.7025,"twenty":-15.830414,"median":44.482394,"eighty":93.840828,"marketCap":412580323},{"date":"2021-06-04","current":-26.725821,"twenty":-15.90012,"median":44.482394,"eighty":93.840828,"marketCap":412940655},{"date":"2021-06-11","current":-27.091182,"twenty":-16.033471,"median":44.482394,"eighty":93.840828,"marketCap":418585859},{"date":"2021-06-18","current":-25.629735,"twenty":-16.113636,"median":44.482394,"eighty":93.840828,"marketCap":396005043},{"date":"2021-06-25","current":-25.684151,"twenty":-16.211273,"median":44.482394,"eighty":93.840828,"marketCap":396845818},{"date":"2021-07-02","current":-27.238882,"twenty":-16.280292,"median":44.482394,"eighty":93.840828,"marketCap":420867962},{"date":"2021-07-09","current":-25.917361,"twenty":-16.381941,"median":44.482394,"eighty":93.840828,"marketCap":400449140},{"date":"2021-07-16","current":-25.458715,"twenty":-16.61715,"median":44.482394,"eighty":93.840828,"marketCap":393362608},{"date":"2021-07-23","current":-25.754114,"twenty":-16.70107,"median":44.482394,"eighty":93.840828,"marketCap":397926815},{"date":"2021-07-30","current":-26.376006,"twenty":-16.867725,"median":44.482394,"eighty":93.840828,"marketCap":407535672},{"date":"2021-08-06","current":-23.241466,"twenty":-17.134848,"median":44.482394,"eighty":93.840828,"marketCap":400241286},{"date":"2021-08-13","current":-21.12541,"twenty":-17.212103,"median":44.482394,"eighty":93.840828,"marketCap":363800685},{"date":"2021-08-20","current":-19.656122,"twenty":-17.353092,"median":44.482394,"eighty":93.840828,"marketCap":338498075},{"date":"2021-08-27","current":-19.656122,"twenty":-17.522336,"median":44.482394,"eighty":93.840828,"marketCap":338498075},{"date":"2021-09-03","current":-20.738755,"twenty":-17.700637,"median":44.482394,"eighty":93.840828,"marketCap":357142104},{"date":"2021-09-10","current":-19.290557,"twenty":-17.899303,"median":44.482394,"eighty":93.840828,"marketCap":332202689},{"date":"2021-09-17","current":-20.30992,"twenty":-18.060321,"median":44.482394,"eighty":93.840828,"marketCap":349757131},{"date":"2021-09-24","current":-22.461126,"twenty":-18.091073,"median":44.482394,"eighty":93.840828,"marketCap":386803058},{"date":"2021-10-01","current":-23.60703,"twenty":-18.425232,"median":44.482394,"eighty":93.840828,"marketCap":406536672},{"date":"2021-10-08","current":-26.123801,"twenty":-18.468453,"median":44.482394,"eighty":93.840828,"marketCap":449877985},{"date":"2021-10-15","current":-27.093953,"twenty":-18.504447,"median":44.482394,"eighty":93.840828,"marketCap":466584972},{"date":"2021-10-22","current":-25.912899,"twenty":-18.647858,"median":44.482394,"eighty":93.840828,"marketCap":446246032},{"date":"2021-10-29","current":-26.278463,"twenty":-18.720372,"median":44.482394,"eighty":93.840828,"marketCap":452541418},{"date":"2021-11-05","current":-27.374652,"twenty":-18.921969,"median":44.482394,"eighty":93.840828,"marketCap":605034567},{"date":"2021-11-12","current":-24.93381,"twenty":-19.161127,"median":44.482394,"eighty":93.840828,"marketCap":551087062},{"date":"2021-11-19","current":-23.828316,"twenty":-19.298993,"median":44.482394,"eighty":93.840828,"marketCap":526653439},{"date":"2021-11-26","current":-22.312367,"twenty":-19.550771,"median":44.482394,"eighty":93.840828,"marketCap":493147926},{"date":"2021-12-03","current":-21.644692,"twenty":-19.661746,"median":44.482394,"eighty":93.840828,"marketCap":478390986},{"date":"2021-12-10","current":-23.926825,"twenty":-19.830468,"median":44.482394,"eighty":93.840828,"marketCap":528830693},{"date":"2021-12-17","current":-35.479789,"twenty":-20.340852,"median":44.482394,"eighty":93.840828,"marketCap":784174295},{"date":"2021-12-23","current":-38.555108,"twenty":-20.692356,"median":44.482394,"eighty":93.840828,"marketCap":852144996},{"date":"2021-12-31","current":-34.904113,"twenty":-21.292726,"median":44.482394,"eighty":93.840828,"marketCap":771450716},{"date":"2022-01-07","current":-33.23011,"twenty":-21.571117,"median":44.47091,"eighty":93.831974,"marketCap":734451886},{"date":"2022-01-14","current":-32.593837,"twenty":-22.321029,"median":44.47091,"eighty":93.831974,"marketCap":720388982},{"date":"2022-01-21","current":-31.056177,"twenty":-22.471872,"median":44.47091,"eighty":93.831974,"marketCap":686403632},{"date":"2022-01-28","current":-29.81393,"twenty":-23.061496,"median":44.47091,"eighty":93.831974,"marketCap":658947486},{"date":"2022-02-04","current":-29.064037,"twenty":-23.582662,"median":44.47091,"eighty":93.831974,"marketCap":642373350},{"date":"2022-02-11","current":-29.783632,"twenty":-23.857812,"median":44.47091,"eighty":93.831974,"marketCap":658277824},{"date":"2022-02-18","current":-28.336868,"twenty":-24.385441,"median":44.47091,"eighty":93.831974,"marketCap":626301460},{"date":"2022-02-25","current":-28.382316,"twenty":-24.728034,"median":44.47091,"eighty":93.831974,"marketCap":627305953},{"date":"2022-03-04","current":-27.473355,"twenty":-25.399635,"median":44.47091,"eighty":93.831974,"marketCap":607216091},{"date":"2022-03-11","current":-27.503654,"twenty":-25.579458,"median":44.47091,"eighty":93.831974,"marketCap":607885753},{"date":"2022-03-18","current":-10.584628,"twenty":-25.602756,"median":44.47091,"eighty":93.831974,"marketCap":450936898},{"date":"2022-03-25","current":-11.332448,"twenty":-25.602756,"median":44.47091,"eighty":93.831974,"marketCap":482796267},{"date":"2022-04-01","current":-11.620114,"twenty":-25.602756,"median":44.47091,"eighty":93.831974,"marketCap":495051732},{"date":"2022-04-08","current":-12.118467,"twenty":-25.602756,"median":44.47091,"eighty":93.831974,"marketCap":516283030},{"date":"2022-04-14","current":-13.030086,"twenty":-25.602756,"median":44.47091,"eighty":93.831974,"marketCap":555120770},{"date":"2022-04-22","current":-13.082758,"twenty":-25.602756,"median":44.47091,"eighty":93.831974,"marketCap":557364729},{"date":"2022-04-29","current":-11.956401,"twenty":-25.602756,"median":44.47091,"eighty":93.831974,"marketCap":509378543},{"date":"2022-05-06","current":-11.109607,"twenty":-25.602756,"median":44.423407,"eighty":93.831974,"marketCap":473302597},{"date":"2022-05-13","current":-6.838809,"twenty":-25.602756,"median":44.326499,"eighty":93.831974,"marketCap":429607173},{"date":"2022-05-20","current":-7.973013,"twenty":-25.602756,"median":44.264099,"eighty":93.831974,"marketCap":500856719},{"date":"2022-05-27","current":-8.009184,"twenty":-25.602756,"median":44.233827,"eighty":93.831974,"marketCap":503128915},{"date":"2022-06-03","current":-7.554469,"twenty":-25.602756,"median":44.233827,"eighty":93.831974,"marketCap":474564176},{"date":"2022-06-10","current":-7.099754,"twenty":-25.602756,"median":44.233827,"eighty":93.831974,"marketCap":445999438},{"date":"2022-06-17","current":-6.298835,"twenty":-25.602756,"median":44.233827,"eighty":93.831974,"marketCap":395686546},{"date":"2022-06-24","current":-7.46921,"twenty":-25.609501,"median":44.218628,"eighty":93.840828,"marketCap":469208288},{"date":"2022-07-01","current":-8.147407,"twenty":-25.609501,"median":44.029158,"eighty":93.840828,"marketCap":511811946},{"date":"2022-07-08","current":-8.125446,"twenty":-25.609501,"median":43.718314,"eighty":93.840828,"marketCap":510432399},{"date":"2022-07-15","current":-8.09961,"twenty":-25.609501,"median":43.551201,"eighty":93.840828,"marketCap":508809402},{"date":"2022-07-22","current":-8.202954,"twenty":-25.609501,"median":43.064392,"eighty":93.840828,"marketCap":515301388},{"date":"2022-07-29","current":-8.848856,"twenty":-25.609501,"median":42.112572,"eighty":93.840828,"marketCap":555876301},{"date":"2022-08-05","current":-8.94445,"twenty":-25.609501,"median":41.698422,"eighty":93.840828,"marketCap":561881388},{"date":"2022-08-12","current":-9.587738,"twenty":-25.609501,"median":41.211613,"eighty":93.840828,"marketCap":610125283},{"date":"2022-08-19","current":-9.160422,"twenty":-25.609501,"median":40.434173,"eighty":93.840828,"marketCap":582932617},{"date":"2022-08-26","current":-9.723353,"twenty":-25.609501,"median":-6.017222,"eighty":93.840828,"marketCap":618755292},{"date":"2022-09-02","current":-9.357448,"twenty":-25.609501,"median":-6.461603,"eighty":93.840828,"marketCap":595470553},{"date":"2022-09-09","current":-9.490504,"twenty":-25.609501,"median":-6.838809,"eighty":93.840828,"marketCap":603937731},{"date":"2022-09-16","current":-9.160422,"twenty":-25.609501,"median":-7.340029,"eighty":93.840828,"marketCap":582932617},{"date":"2022-09-23","current":-8.113882,"twenty":-25.609501,"median":-7.46921,"eighty":93.840828,"marketCap":516335008},{"date":"2022-09-30","current":-8.22391,"twenty":-25.609501,"median":-7.665564,"eighty":93.840828,"marketCap":523336712},{"date":"2022-10-07","current":-8.254615,"twenty":-25.609501,"median":-7.797328,"eighty":93.840828,"marketCap":525290676},{"date":"2022-10-14","current":-8.500258,"twenty":-25.609501,"median":-7.91359,"eighty":93.840828,"marketCap":540922389},{"date":"2022-10-21","current":-9.242303,"twenty":-25.609501,"median":-8.0066,"eighty":93.840828,"marketCap":588143188},{"date":"2022-10-28","current":-9.961319,"twenty":-25.609501,"median":-8.102194,"eighty":93.840828,"marketCap":633898513},{"date":"2022-11-04","current":-9.810351,"twenty":-25.609501,"median":-8.182285,"eighty":93.840828,"marketCap":624291523},{"date":"2022-11-11","current":-9.043105,"twenty":-25.609501,"median":-8.22391,"eighty":93.840828,"marketCap":613023068},{"date":"2022-11-18","current":-9.514501,"twenty":-25.609501,"median":-8.355252,"eighty":93.72897,"marketCap":644978525},{"date":"2022-11-25","current":-10.019568,"twenty":-25.609501,"median":-8.433729,"eighty":93.149414,"marketCap":679216516},{"date":"2022-12-02","current":-9.33893,"twenty":-25.609501,"median":-8.569345,"eighty":92.137422,"marketCap":633076748},{"date":"2022-12-09","current":-9.500071,"twenty":-25.609501,"median":-8.699842,"eighty":91.159402,"marketCap":644000297},{"date":"2022-12-16","current":-9.156144,"twenty":-25.609501,"median":-8.830771,"eighty":90.084372,"marketCap":620685856},{"date":"2022-12-23","current":-9.488045,"twenty":-25.609501,"median":-8.885027,"eighty":88.207549,"marketCap":643185107},{"date":"2022-12-30","current":-9.675642,"twenty":-25.609501,"median":-8.94445,"eighty":85.476822,"marketCap":655902075},{"date":"2023-01-06","current":-10.563117,"twenty":-25.609501,"median":-9.037601,"eighty":84.678021,"marketCap":716063115},{"date":"2023-01-13","current":-10.570332,"twenty":-25.609501,"median":-9.055512,"eighty":83.785101,"marketCap":716552229},{"date":"2023-01-20","current":-10.106151,"twenty":-25.609501,"median":-9.156144,"eighty":81.714404,"marketCap":685085886},{"date":"2023-01-27","current":-10.488559,"twenty":-25.609501,"median":-9.178333,"eighty":79.307707,"marketCap":711008936},{"date":"2023-02-03","current":-10.743498,"twenty":-25.609501,"median":-9.319066,"eighty":78.151242,"marketCap":728290969},{"date":"2023-02-10","current":-10.822865,"twenty":-25.609501,"median":-9.34374,"eighty":74.795751,"marketCap":733671225},{"date":"2023-02-17","current":-10.36109,"twenty":-25.609501,"median":-9.437539,"eighty":73.316501,"marketCap":702367919},{"date":"2023-02-24","current":-9.892099,"twenty":-25.609501,"median":-9.463995,"eighty":72.702367,"marketCap":670575499},{"date":"2023-03-03","current":-10.933499,"twenty":-25.435394,"median":-9.467475,"eighty":72.512607,"marketCap":741170975},{"date":"2023-03-10","current":-13.950056,"twenty":-24.971129,"median":-9.467475,"eighty":72.512607,"marketCap":668151872},{"date":"2023-03-17","current":-13.434525,"twenty":-24.508031,"median":-9.467475,"eighty":72.512607,"marketCap":643460014},{"date":"2023-03-24","current":-12.84047,"twenty":-23.901482,"median":-9.467475,"eighty":72.512607,"marketCap":615007144},{"date":"2023-03-31","current":-13.560847,"twenty":-23.734185,"median":-9.47776,"eighty":72.457404,"marketCap":649510337},{"date":"2023-04-06","current":-13.103356,"twenty":-23.276616,"median":-9.47776,"eighty":72.457404,"marketCap":627598357},{"date":"2023-04-14","current":-14.566675,"twenty":-22.927503,"median":-9.467475,"eighty":72.512607,"marketCap":697685448},{"date":"2023-04-21","current":-14.813567,"twenty":-22.372547,"median":-9.467475,"eighty":72.512607,"marketCap":709510626},{"date":"2023-04-28","current":-13.949443,"twenty":-21.607296,"median":-9.467475,"eighty":72.512607,"marketCap":668122506},{"date":"2023-05-05","current":-14.230003,"twenty":-21.372869,"median":-9.467475,"eighty":72.512607,"marketCap":681560207},{"date":"2023-05-11","current":-29.794637,"twenty":-21.500816,"median":-9.500071,"eighty":72.007154,"marketCap":784403414},{"date":"2023-05-19","current":-56.777451,"twenty":-22.064999,"median":-9.532539,"eighty":71.204986,"marketCap":1494779963},{"date":"2023-05-26","current":-32.844617,"twenty":-22.451972,"median":-9.621527,"eighty":70.195747,"marketCap":864700227},{"date":"2023-06-02","current":-33.036774,"twenty":-22.980041,"median":-9.652793,"eighty":69.862862,"marketCap":869759145},{"date":"2023-06-09","current":-35.484997,"twenty":-23.178195,"median":-9.670148,"eighty":68.90026,"marketCap":934213507},{"date":"2023-06-16","current":-36.089935,"twenty":-23.724334,"median":-9.72975,"eighty":67.226918,"marketCap":950139730},{"date":"2023-06-23","current":-36.68064,"twenty":-23.894858,"median":-9.77906,"eighty":63.86816,"marketCap":965691218},{"date":"2023-06-30","current":-38.082675,"twenty":-24.395292,"median":-9.853618,"eighty":61.559985,"marketCap":1002602582},{"date":"2023-07-07","current":-38.075558,"twenty":-24.746642,"median":-9.912543,"eighty":60.9286,"marketCap":1002415215},{"date":"2023-07-14","current":-35.976065,"twenty":-25.402745,"median":-10.017163,"eighty":60.493876,"marketCap":947141853},{"date":"2023-07-21","current":-36.780277,"twenty":-25.583596,"median":-10.097734,"eighty":60.038451,"marketCap":968314361},{"date":"2023-07-28","current":-36.68064,"twenty":-25.679487,"median":-10.317799,"eighty":59.150503,"marketCap":965691218},{"date":"2023-08-04","current":-37.136124,"twenty":-25.757224,"median":-10.457372,"eighty":56.817084,"marketCap":977682727},{"date":"2023-08-11","current":-222.079037,"twenty":-25.850737,"median":-10.495794,"eighty":54.293227,"marketCap":1145705754},{"date":"2023-08-18","current":-219.587884,"twenty":-25.917361,"median":-10.583761,"eighty":54.037177,"marketCap":1132853892},{"date":"2023-08-25","current":-232.080287,"twenty":-26.074388,"median":-10.682168,"eighty":53.63505,"marketCap":1197302203},{"date":"2023-09-01","current":-235.890287,"twenty":-26.135023,"median":-10.804827,"eighty":53.39322,"marketCap":1216957993},{"date":"2023-09-08","current":-229.662403,"twenty":-26.198767,"median":-10.842106,"eighty":53.156773,"marketCap":1184828336},{"date":"2023-09-15","current":-233.032787,"twenty":-26.325403,"median":-10.964765,"eighty":53.067365,"marketCap":1202216150},{"date":"2023-09-22","current":-217.353172,"twenty":-26.546851,"median":-11.360809,"eighty":52.793727,"marketCap":1121325015},{"date":"2023-09-29","current":-215.741249,"twenty":-26.616774,"median":-11.672785,"eighty":52.273601,"marketCap":1113009104},{"date":"2023-10-06","current":-214.788749,"twenty":-26.733499,"median":-11.954375,"eighty":50.934555,"marketCap":1108095156},{"date":"2023-10-13","current":-212.260961,"twenty":-27.062768,"median":-12.073899,"eighty":50.197317,"marketCap":1095054296},{"date":"2023-10-20","current":-209.95298,"twenty":-27.148708,"median":-12.393978,"eighty":49.856152,"marketCap":1083147423},{"date":"2023-10-27","current":-221.566153,"twenty":-27.192662,"median":-12.734037,"eighty":49.51106,"marketCap":1143059783},{"date":"2023-11-03","current":-229.186153,"twenty":-27.249765,"median":-13.028246,"eighty":49.395552,"marketCap":1182371362},{"date":"2023-11-10","current":74.513877,"twenty":-27.312133,"median":-13.082758,"eighty":49.346018,"marketCap":997070186},{"date":"2023-11-17","current":73.087774,"twenty":-27.312133,"median":-13.082758,"eighty":49.346018,"marketCap":977987503},{"date":"2023-11-24","current":73.943436,"twenty":-27.312133,"median":-13.082758,"eighty":49.346018,"marketCap":989437113},{"date":"2023-12-01","current":71.034186,"twenty":-27.312133,"median":-13.082758,"eighty":49.346018,"marketCap":950508440},{"date":"2023-12-08","current":69.493995,"twenty":-27.294941,"median":-13.056422,"eighty":49.358996,"marketCap":929899142},{"date":"2023-12-15","current":75.440844,"twenty":-27.312133,"median":-13.082758,"eighty":49.346018,"marketCap":1009473930},{"date":"2023-12-22","current":75.768847,"twenty":-27.312133,"median":-13.082758,"eighty":49.346018,"marketCap":1013862947},{"date":"2023-12-29","current":78.178961,"twenty":-27.329324,"median":-13.093057,"eighty":49.324601,"marketCap":1046112682},{"date":"2024-01-05","current":80.047156,"twenty":-27.346516,"median":-13.103356,"eighty":49.293085,"marketCap":1071110996},{"date":"2024-01-12","current":79.562281,"twenty":-27.346516,"median":-13.103356,"eighty":49.293085,"marketCap":1064622884},{"date":"2024-01-19","current":79.277061,"twenty":-27.363707,"median":-13.103356,"eighty":49.274727,"marketCap":1060806347},{"date":"2024-01-26","current":77.437388,"twenty":-27.346516,"median":-13.103356,"eighty":49.293085,"marketCap":1036189686},{"date":"2024-02-02","current":80.589075,"twenty":-27.346516,"median":-13.103356,"eighty":49.293085,"marketCap":1078362416},{"date":"2024-02-09","current":79.733413,"twenty":-27.346516,"median":-13.103356,"eighty":49.293085,"marketCap":1066912806},{"date":"2024-02-16","current":82.072222,"twenty":-27.346516,"median":-13.103356,"eighty":49.293085,"marketCap":1098208406},{"date":"2024-02-23","current":82.927884,"twenty":-27.346516,"median":-13.103356,"eighty":49.293085,"marketCap":1109658016},{"date":"2024-03-01","current":71.050516,"twenty":-27.329324,"median":-13.093057,"eighty":49.324601,"marketCap":1334257645},{"date":"2024-03-08","current":70.042559,"twenty":-27.329324,"median":-13.093057,"eighty":49.411858,"marketCap":1315329208},{"date":"2024-03-15","current":69.349588,"twenty":-27.329324,"median":-13.093057,"eighty":49.604826,"marketCap":1302315908},{"date":"2024-03-22","current":72.782944,"twenty":-27.329324,"median":-13.093057,"eighty":49.993478,"marketCap":1366790897},{"date":"2024-03-28","current":73.171427,"twenty":-27.329324,"median":-13.093057,"eighty":49.993478,"marketCap":1374086232},{"date":"2024-04-05","current":71.334004,"twenty":-27.346516,"median":-13.103356,"eighty":49.894276,"marketCap":1339581268},{"date":"2024-04-12","current":76.093972,"twenty":-27.346516,"median":-13.103356,"eighty":49.894276,"marketCap":1428968709},{"date":"2024-04-19","current":72.15018,"twenty":-27.346516,"median":-13.103356,"eighty":49.894276,"marketCap":1354908226},{"date":"2024-04-26","current":72.563552,"twenty":-27.329324,"median":-13.093057,"eighty":49.993478,"marketCap":1362670939},{"date":"2024-05-03","current":74.976751,"twenty":-27.329324,"median":-13.093057,"eighty":49.993478,"marketCap":1407988402},{"date":"2024-05-10","current":73.602568,"twenty":-27.329324,"median":-13.093057,"eighty":49.993478,"marketCap":1382182625},{"date":"2024-05-17","current":34.818397,"twenty":-27.329324,"median":-13.093057,"eighty":49.604826,"marketCap":1237689546},{"date":"2024-05-24","current":32.956538,"twenty":-27.329324,"median":-13.093057,"eighty":49.398269,"marketCap":1171506053},{"date":"2024-05-31","current":34.649137,"twenty":-27.329324,"median":-13.093057,"eighty":49.201225,"marketCap":1231672865},{"date":"2024-06-07","current":37.575695,"twenty":-27.329324,"median":-13.093057,"eighty":49.058538,"marketCap":1335703224},{"date":"2024-06-14","current":34.529017,"twenty":-27.346516,"median":-13.103356,"eighty":48.618246,"marketCap":1227402962},{"date":"2024-06-21","current":32.426918,"twenty":-27.363707,"median":-13.103356,"eighty":48.282592,"marketCap":1152679664},{"date":"2024-06-28","current":34.447117,"twenty":-27.368103,"median":-13.144326,"eighty":47.697066,"marketCap":1224491665},{"date":"2024-07-05","current":33.207698,"twenty":-27.368103,"median":-13.144326,"eighty":47.191366,"marketCap":1180434032},{"date":"2024-07-12","current":35.080476,"twenty":-27.368103,"median":-13.144326,"eighty":46.545561,"marketCap":1247005698},{"date":"2024-07-15","current":34.670977,"twenty":-27.368103,"median":-13.144326,"eighty":46.458973,"marketCap":1232449211},{"date":"2024-08-02","current":34.862077,"twenty":-27.415745,"median":-13.397035,"eighty":45.466555,"marketCap":1239242238},{"date":"2024-08-09","current":40.770114,"twenty":-27.415745,"median":-13.397035,"eighty":45.054829,"marketCap":1101404633},{"date":"2024-08-16","current":44.144143,"twenty":-27.415745,"median":-13.397035,"eighty":44.802371,"marketCap":1192554015},{"date":"2024-08-23","current":43.725098,"twenty":-27.415745,"median":-13.397035,"eighty":44.635258,"marketCap":1181233535},{"date":"2024-08-30","current":45.119504,"twenty":-27.415745,"median":-13.397035,"eighty":44.702103,"marketCap":1218903409},{"date":"2024-09-06","current":43.898496,"twenty":-27.415745,"median":-13.397035,"eighty":44.847419,"marketCap":1185917872},{"date":"2024-09-13","current":40.567817,"twenty":-27.415745,"median":-13.397035,"eighty":44.64979,"marketCap":1095939574},{"date":"2024-09-20","current":43.62395,"twenty":-27.415745,"median":-13.397035,"eighty":44.561555,"marketCap":1178501006},{"date":"2024-09-27","current":42.121171,"twenty":-27.415745,"median":-13.397035,"eighty":44.436175,"marketCap":1137903422},{"date":"2024-10-04","current":41.030211,"twenty":-27.415745,"median":-13.397035,"eighty":44.244358,"marketCap":1108431138},{"date":"2024-10-11","current":39.809202,"twenty":-27.415745,"median":-13.397035,"eighty":44.115243,"marketCap":1075445601},{"date":"2024-10-18","current":43.436102,"twenty":-27.415745,"median":-13.397035,"eighty":43.717962,"marketCap":1173426308},{"date":"2024-10-25","current":42.829211,"twenty":-27.415745,"median":-13.397035,"eighty":43.625385,"marketCap":1157031130},{"date":"2024-10-31","current":42.272893,"twenty":-27.415745,"median":-13.397035,"eighty":43.412983,"marketCap":1142002217},{"date":"2024-11-08","current":42.17897,"twenty":-27.424001,"median":-13.427697,"eighty":43.200989,"marketCap":1139464868},{"date":"2024-11-15","current":-162.206247,"twenty":-27.58243,"median":-13.5568,"eighty":43.200989,"marketCap":1150204495},{"date":"2024-11-22","current":-153.808198,"twenty":-27.970377,"median":-13.659856,"eighty":43.200989,"marketCap":1090653931},{"date":"2024-11-29","current":-157.580436,"twenty":-28.373227,"median":-13.949443,"eighty":43.137369,"marketCap":1117402873},{"date":"2024-12-06","current":-154.166148,"twenty":-28.925081,"median":-14.069148,"eighty":43.103757,"marketCap":1093192152},{"date":"2024-12-13","current":-155.735619,"twenty":-29.536697,"median":-14.163523,"eighty":42.711788,"marketCap":1104321274},{"date":"2024-12-20","current":-149.402664,"twenty":-29.809386,"median":-14.230003,"eighty":42.389937,"marketCap":1059414291},{"date":"2024-12-27","current":-152.816953,"twenty":-30.032369,"median":-14.259929,"eighty":42.268559,"marketCap":1083625012},{"date":"2025-01-03","current":-152.651745,"twenty":-30.59903,"median":-14.334745,"eighty":42.15296,"marketCap":1082453526},{"date":"2025-01-10","current":-149.127318,"twenty":-31.037127,"median":-14.458652,"eighty":42.12984,"marketCap":1057461814},{"date":"2025-01-17","current":-158.32387,"twenty":-31.451576,"median":-14.562095,"eighty":41.997389,"marketCap":1122674562},{"date":"2025-01-24","current":-161.600486,"twenty":-32.125167,"median":-14.692664,"eighty":41.686231,"marketCap":1145909044},{"date":"2025-01-31","current":-163.995995,"twenty":-32.844617,"median":-14.754511,"eighty":41.125579,"marketCap":1162895599},{"date":"2025-02-07","current":-165.730674,"twenty":-33.21612,"median":-14.853009,"eighty":40.589491,"marketCap":1175196207},{"date":"2025-02-14","current":-162.977215,"twenty":-34.503504,"median":-14.943931,"eighty":39.583785,"marketCap":1155671432},{"date":"2025-02-21","current":-164.298875,"twenty":-35.196049,"median":-15.022224,"eighty":36.693359,"marketCap":1165043324},{"date":"2025-02-28","current":-150.283771,"twenty":-35.482914,"median":-15.15608,"eighty":35.417904,"marketCap":1065662219},{"date":"2025-03-07","current":-66.935633,"twenty":-35.801182,"median":-15.325295,"eighty":34.853341,"marketCap":1239781788},{"date":"2025-03-14","current":-67.379677,"twenty":-36.374044,"median":-15.537445,"eighty":34.638217,"marketCap":1248006384},{"date":"2025-03-21","current":-70.553775,"twenty":-36.543996,"median":-15.658673,"eighty":34.391425,"marketCap":1306797020},{"date":"2025-03-28","current":-74.950366,"twenty":-36.777718,"median":-15.830414,"eighty":33.702373,"marketCap":1388230680},{"date":"2025-04-04","current":-74.873618,"twenty":-37.127584,"median":-15.916284,"eighty":33.489434,"marketCap":1386809145},{"date":"2025-04-11","current":-71.398008,"twenty":-37.352695,"median":-16.052665,"eighty":33.190226,"marketCap":1322433907},{"date":"2025-04-15","current":-75.345073,"twenty":-37.523284,"median":-16.067819,"eighty":32.74469,"marketCap":1395541433}],"updateTime":1744817087098}}}